Skip to main content
OpenTrials
Completed

NCT Number: NCT05919706

Mobile Technology and Motivational Interviewing in Type 2 Diabetes Patients

Type 2 diabetes patients were divided into experimental and control groups. Patients in the control group received regular nursing care, while those in the experimental group received MI, which is empowered by game-based mobile technology. Pre-test, post-test and follow-up test self-management, quality of life and satisfaction levels scores were determined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Mellitus Behavior Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Gaming Glucose Metabolism Disorders Metabolic Diseases Mobile Technology Motivational Interviewing Nutritional and Metabolic Diseases Personal Satisfaction Quality of Life Self-management

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bingol State Hospital

Bingoel, Centrer, Turkey (Türkiye)

About this study

A randomized controlled and experimental study design was used to conduct this research on 64 patients with Type 2 DM. Purpose of this study was to explore how motivational interviewing powered by game-based mobile technology affected self-management, quality of life, and satisfaction in Type 2 diabetes patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being 18 years or older,
  • Having a diagnosis of Type 2 Diabetes Mellitus according to the ADA diagnostic criteria,
  • Being on oral antidiabetic and/or insulin therapy,
  • Having a smart phone and knowing how to use it,
  • Internet connection (to install mobile technology application),
  • Not having participated in motivational interviewing (MG) training before,
  • Not having vision and hearing problems,
  • Not having a communication problem,
  • To be able to read, write and speak Turkish,
  • Volunteering to participate in the study and continue the study process.

Exclusion criteria

  • Having a diagnosis of Type 1 and/or Gestational Diabetes Mellitus,
  • Having serious health problems that prevent participation in motivational interviewing,
  • Using steroid therapy,
  • Having complications that may develop in the long term due to diabetes and having advanced retinopathy, neuropathy, amputation history or active foot wound,
  • Having mental confusion, having any psychiatric problems and/or using a psychiatric drug,
  • Being unwilling to participate in the study and/or not wanting to continue the study process.

Treatment and study plan

Patient Education with Game-Based Mobile Technology and Motivational Interviewing

Behavioral

Education program, game-based mobile technology and motivational interview were applied to the patients in the experimental group. The patients' self-management, quality of life, and satisfaction level scores for the intervention were determined.

Primary outcomes

  1. DSMQ

    Time frame: Last 8 weeks

    The scale is of a four-point Likert type. The scale has 4 sub-dimensions as "Glucose Management, Diet Control, Physical Activity, Health-Care Use" and a total score. The lowest score of the scale is 0 points and the highest score is 10 points. The higher the score, the higher the diabetes self-management.

  2. SF-36

    Time frame: Last 4 weeks

    The scale consists of 36 items and 8 sub-dimensions. 8 sub-dimensions have 2 summary sub-dimensions as "Physical Health and Mental Health". There is no total score in the scale. A score between 0-100 is evaluated with sub-dimensions (0: Poor Health, 100: Good Health). Low scores on the scale indicate poor health, while high scores indicate good health.

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Official study title

The Effect of Motivational Interview Empowered by Mobile Technology on Self Management, Quality of Life and Satisfaction Level in Type 2 Diabetic Patients

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jun 26, 2023
Registry last updated
Jun 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.